Lumito
0.86 SEK +7.5%Be the first to follow this company
Lumito specializes in medical technology for digital pathology. The company strives to improve tissue diagnostics with its patented technology based on upconverted nanoparticles. The company plans to initially launch its first product for research laboratories. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito has its headquarters in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
LUMITO
Daily low / high price
0.78 / 0.88
SEK
Market cap
200.97M SEK
Turnover
325.36K SEK
Volume
395K
Financial calendar
Interim report
2024-10-31
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.4 % | 7.4 % |
Nordnet Pensionsförsäkring AB | 2.4 % | 2.4 % |
Mats Olsby | 1.4 % | 1.4 % |
Håkan Andersson | 1.3 % | 1.3 % |
Peter Norman Eggers | 1.3 % | 1.3 % |
Robert Eriksson | 1.1 % | 1.1 % |
MTT Capital | 1.0 % | 1.0 % |
DMC Byggnads AB | 0.9 % | 0.9 % |
Stefan Andersson Engels | 0.9 % | 0.9 % |
Mathias Joelsson | 0.9 % | 0.9 % |
ShowingAll content types
Lumito deltar vid European Congress of Pathology i Florens
Lumito AB publicerar kvartalsrapport 2, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools